Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Solidaginis herba extract** is a herbal preparation derived from the dried, flowering aerial parts of plants of the genus Solidago, commonly *Solidago virgaurea* (European goldenrod) or *Solidago canadensis* (Canadian goldenrod)[1][3][5]. This extract contains a rich array of bioactive constituents including **flavonoids** (e.g., quercetin, kaempferol, rutin), **phenolic acids** (e.g., caffeic, chlorogenic, gallic, ferulic, vanillic), **triterpene saponins** (oleanane-type), and essential oils (e.g., germacrene D, limonene, bornyl acetate)[1][3]. It is traditionally and empirically used as a **diuretic**, for **urinary tract irrigation** (especially in cases of inflammation and renal gravel), and as an **adjuvant in the treatment of bacterial infections of the urinary tract**[3][8]. Experimental and clinical evidence shows **anti-inflammatory**, **antioxidant**, **antimicrobial** (active against *Staphylococcus aureus*, *Enterococcus faecalis*, *Streptococcus pyogenes*), spasmolytic, analgesic, hepatoprotective, and wound-healing properties[1][3][5][6][8]. **Flavonoid and phenolic fractions** are believed responsible for much of the anti-inflammatory activity, acting partly as **COX-1 and COX-2 inhibitors**[1]. The extract is generally considered **non-toxic** (toxicity class V, LD₅₀ > 5000 mg/kg)[1]. **Route of administration** includes oral (tablets, capsules, teas, 3D-printed gels), topical (ointments for wound healing), and liquid oral/infusion forms[7][8]. **Standardization** (European Pharmacopoeia) typically requires a minimum flavonoid content of 0.5% (expressed as hyperoside)[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on solidaginis herba extract.